F Joel Leong Selected Research

ganaplacide

10/2021	Safety, Pharmacokinetics, and Causal Prophylactic Efficacy of KAF156 in a Plasmodium falciparum Human Infection Study.
1/2016	Antimalarial Activity of KAF156 in Falciparum and Vivax Malaria.
11/2014	A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel Imidazolopiperazine KAF156 to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

F Joel Leong Research Topics

Disease

3	Malaria 10/2021 - 10/2014
2	Infections 10/2021 - 01/2017
2	Cryptosporidiosis 01/2017 - 12/2016
2	Vivax Malaria 01/2016 - 07/2014
2	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2016 - 07/2014
1	Parasitic Diseases (Parasitic Disease) 10/2021
1	Hematoma 10/2014
1	Nausea 10/2014
1	Diarrhea 10/2014
1	Dizziness (Lightheadedness) 10/2014
1	Headache (Headaches) 10/2014
1	Parasitemia 07/2014

Drug/Important Bio-Agent (IBA)

3	ganaplacideIBA 10/2021 - 11/2014
2	Pharmaceutical PreparationsIBA 01/2017 - 12/2016
2	Antimalarials (Antimalarial Agents)IBA 01/2016 - 11/2014
2	NITD 609IBA 10/2014 - 07/2014
1	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 10/2021
1	proguanil drug combination atovaquone (malarone)FDA Link 10/2021
1	pyrazolopyridineIBA 01/2017
1	LipidsIBA 01/2017
1	KDU731IBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	nitazoxanide (NTZ)FDA Link 12/2016
1	ArtesunateIBA 07/2014

Therapy/Procedure

1	Therapeutics 12/2016
1	Aftercare (After-Treatment) 01/2016
1	Catheters 10/2014